CD8A and hepatocellular carcinoma: CircCCNY can enhance CD8+ T-cell infiltration and suppress immune evasion by inhibiting the MAPK/c-Myc/programmed death ligand-1 (PD-L1) signaling pathway in hepatocellular carcinoma (HCC) cells [54].